Corient Private Wealth LP Acquires New Position in Aflac Incorporated $AFL

Posted by Stanley Muller on Aug 28th, 2026

Corient Private Wealth LP purchased a new position in shares of Aflac Incorporated (NYSE:AFL – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 534,110 shares of the financial services provider’s stock, valued at approximately $62,624,000. Corient Private Wealth LP owned approximately 0.11% of Aflac as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. DNB Asset Management AS lifted its holdings in shares of Aflac by 51.3% during the fourth quarter. DNB Asset Management AS now owns 168,003 shares of the financial services provider’s stock worth $18,526,000 after purchasing an additional 56,975 shares during the period. Employees Retirement System of Texas acquired a new stake in Aflac in the fourth quarter valued at $3,743,000. Meiji Yasuda Asset Management Co Ltd. bought a new position in Aflac during the 2nd quarter worth $6,630,000. Atlas Wealth LLC bought a new position in Aflac during the 1st quarter worth $1,802,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Aflac by 4.5% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,072,717 shares of the financial services provider’s stock worth $118,256,000 after buying an additional 46,262 shares during the period. Institutional investors own 67.44% of the company’s stock.

Insider Activity

In related news, major shareholder Post Holdings Co. Ltd. Japan sold 12,700 shares of the company’s stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $116.49, for a total value of $1,479,423.00. Following the sale, the insider directly owned 50,765,590 shares of the company’s stock, valued at $5,913,683,579.10. This represents a 0.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Joseph L. Moskowitz sold 600 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $124.10, for a total transaction of $74,460.00. Following the transaction, the director directly owned 32,710 shares of the company’s stock, valued at $4,059,311. This represents a 1.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 502,125 shares of company stock worth $58,965,806 over the last three months. 0.80% of the stock is owned by insiders.

Aflac Price Performance

AFL opened at $116.45 on Friday. Aflac Incorporated has a twelve month low of $104.66 and a twelve month high of $130.22. The company has a market capitalization of $58.38 billion, a price-to-earnings ratio of 12.48, a PEG ratio of 1.89 and a beta of 0.60. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 0.29. The firm has a 50-day moving average price of $121.60 and a 200-day moving average price of $116.21.

Aflac (NYSE:AFL – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The financial services provider reported $1.75 earnings per share for the quarter, missing the consensus estimate of $1.76 by ($0.01). The firm had revenue of $4.22 billion during the quarter, compared to the consensus estimate of $4.11 billion. Aflac had a return on equity of 13.27% and a net margin of 26.91%.The company’s revenue for the quarter was down 1.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.78 EPS. Equities analysts expect that Aflac Incorporated will post 7.04 EPS for the current year.

Aflac Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Wednesday, August 19th will be issued a $0.61 dividend. This represents a $2.44 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Wednesday, August 19th. Aflac’s dividend payout ratio (DPR) is 26.15%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Wells Fargo & Company set a $122.00 price target on Aflac and gave the company an “equal weight” rating in a research note on Wednesday, August 19th. Mizuho set a $116.00 price objective on shares of Aflac in a research report on Monday, August 10th. Barclays reiterated an “underweight” rating and issued a $99.00 price objective (up from $98.00) on shares of Aflac in a research note on Friday, August 7th. Keefe, Bruyette & Woods boosted their target price on shares of Aflac from $120.00 to $125.00 and gave the company a “market perform” rating in a research report on Tuesday, August 11th. Finally, Wall Street Zen lowered shares of Aflac from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, seven have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $116.62.

Check Out Our Latest Report on Aflac

Aflac Profile

(Free Report)

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.